Sodium Iodide I-131

BreastfeedingGeriatricPediatric
  • TRADE NAME: Hicon (DraxImage)
  • INDICATIONS: Hyperthyroidism and selected cases of carcinoma of the thyroid
  • CLASS: Radiopharmaceutical
  • HALF-LIFE: 8 days
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Antithyroid agents, Beta blockers, Propranolol

PREGNANCY CATEGORY: X

Contra-indicated in women who are, or who may become pregnant. Patients with vomiting and diarrhea should not receive radioiodide and concurrent antithyroid therapy should be discontinued 3-4 days before administration.

Our database has 4 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN.
GASTROINTESTINAL/HEPATIC.
LOCAL.
RESPIRATORY.


Page last updated 08/02/2021

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top